Baseline Cerebrospinal Fluid α-Synuclein in Parkinson’s Disease Is Associated with Disease Progression and Cognitive Decline

Biomarkers are increasingly recognized as tools in the diagnosis and prognosis of neurodegenerative diseases. No fluid biomarker for Parkinson’s disease (PD) has been established to date, but α-synuclein, a major component of Lewy bodies in PD and dementia with Lewy bodies (DLB), has become a promis...

Descripción completa

Detalles Bibliográficos
Autores principales: Emdina, Anna, Hermann, Peter, Varges, Daniela, Nuhn, Sabine, Goebel, Stefan, Bunck, Timothy, Maass, Fabian, Schmitz, Matthias, Llorens, Franc, Kruse, Niels, Lingor, Paul, Mollenhauer, Brit, Zerr, Inga
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9140902/
https://www.ncbi.nlm.nih.gov/pubmed/35626415
http://dx.doi.org/10.3390/diagnostics12051259

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9140902/
https://www.ncbi.nlm.nih.gov/pubmed/35626415
http://dx.doi.org/10.3390/diagnostics12051259

Ejemplares similares